Skip to main content
. Author manuscript; available in PMC: 2017 Oct 27.
Published in final edited form as: J Oncol Pract. 2016 Dec 20;13(2):e98–e107. doi: 10.1200/JOP.2016.014100

Fig 1.

Fig 1

Medicare encounter days 1 year after curative treatment of stage I non–small cell lung cancer. *Cancer-related treatment burden was determined by subtracting the non–cancer-related encounter days in the year before treatment initiation from the total encounter days in the year after treatment initiation.